Market Cap (In AUD)
49.29 Million
Revenue (In AUD)
460.39 Thousand
Net Income (In AUD)
-8.88 Million
Avg. Volume
1.38 Million
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.016-0.042
- PE
- -
- EPS
- -
- Beta Value
- 1.268
- ISIN
- AU000000ADO8
- CUSIP
- Q0424V101
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. David John Radford B.Sc., BSc (Hons), M.B.A., MAICD
- Employee Count
- -
- Website
- https://www.anteotech.com
- Ipo Date
- 2000-04-06
- Details
- AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
More Stocks
-
WEW
-
FELTFFuji Electric Co., Ltd.
FELTF
-
7003
-
FAF
-
NTN
-
CBBHF
-
ACC
-
CEJOFCresco Ltd.
CEJOF